Inicure was pitched by CEO Peter Olofsson-Sahl at GoWest – Nordic capital 28-29 January 2026. Inicures approach to combat the threat from AMR received great attention from investors and future partners. So many interesting connections, fruitful discussions, and meetings with old and new friends.
Pitching Inicure at GoWest – Nordical capital
Seal of Excellence – EIC – Transition proposal iCURE
The EIC-Transition proposal — iCURE “Novel small molecule FPR1 agonists for treating antibiotic-resistant and chronic bacterial infections” coordinated
Immunotherapies & Innovations for Infectious Diseases Congress (I4ID2025) – Lyon France
Invited as presenter at the Immunotherapies & Innovations for Infectious Diseases Congress (#I4ID2025) – in Lyon, CEO of
Nordic Life Science Days 2025 Göteborg Sweden
Chairman Dr Sara Malcus and CEO Peter Olofsson-Sahl participated in the Nordic Life Science days. Reconnecting with several
